Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Merz Pharma GmbH & Co KgaA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0153
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair care, vitamins and minerals, and dental devices. It offers products for various therapeutic areas such as Alzheimer’s disease, depression, dystonia, hair loss, liver diseases, Parkinson’s disease, cold, scars, wrinkles and other skin disorders. The company also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. It operates in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt am Main, Germany.

Merz Pharma GmbH & Co KgaA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deal Details 10
Venture Financing 10
Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10
Cytrellis Biosystems Raises Funds through Venture Financing 11
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 12
Partnerships 13
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Equity Offering 14
Ulthera Withdraws IPO 14
Acquisition 15
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA – Key Competitors 21
Merz Pharma GmbH & Co KgaA – Key Employees 22
Merz Pharma GmbH & Co KgaA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Corporate Communications 25
Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America 25
Product News 26
May 18, 2017: Merz Celebrates a Monumental Milestone: One Million Treatments Worldwide With Ultherapy 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Merz Pharma GmbH & Co KgaA, Medical Equipment, Key Facts 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Deals By Market, 2012 to YTD 2018 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10
Cytrellis Biosystems Raises Funds through Venture Financing 11
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 12
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Ulthera Withdraws IPO 14
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA, Key Competitors 21
Merz Pharma GmbH & Co KgaA, Key Employees 22
Merz Pharma GmbH & Co KgaA, Other Locations 23
Merz Pharma GmbH & Co KgaA, Subsidiaries 23

List of Figures
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ramky Infrastructure Limited:企業の戦略・SWOT・財務情報
    Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • YRC Worldwide Inc (YRCW):企業の財務・戦略的SWOT分析
    YRC Worldwide Inc (YRCW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hansa Medical AB (HMED):製薬・医療:M&Aディール及び事業提携情報
    Summary Hansa Medical AB (Hansa Medical) is a biopharmaceutical company that focuses on the development of novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The company's lead project, IdeS is a proprietary antibody-degrading enzyme in late stage clinical development …
  • Per Aarsleff Holding AS (PAAL B):企業の財務・戦略的SWOT分析
    Per Aarsleff Holding AS (PAAL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Zogenix Inc (ZGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Zogenix Inc (Zogenix) is a pharmaceutical company with focus on central nervous system (CNS) disorders. It develops and commercializes therapies for rare CNS disorders. The company’s lead product candidate ZX008 (low dose fenfluramine) is intended for the treatment of Dravet syndrome and Len …
  • The Vanguard Group, Inc.:企業の戦略的SWOT分析
    The Vanguard Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Selex Gruppo Commerciale S.p.A.:企業の戦略・SWOT・財務情報
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Clariant Ltd.:企業のM&A・事業提携・投資動向
    Clariant Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Clariant Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Argenx SE (ARGX):企業の財務・戦略的SWOT分析
    Summary Argenx SE (Argenx) is a human antibodies developer. The company offers autoimmunity and oncology products. Its wholly owned product candidates include ARGX-113, ARGX-110, ARGX-117 and ARGX-111. Argenx partnered product candidates are ARGX-109, ARGX-112, ARGX-115 AND ARGX-116. The company off …
  • Bonduelle Sca:企業の戦略・SWOT・財務分析
    Bonduelle Sca - Strategy, SWOT and Corporate Finance Report Summary Bonduelle Sca - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Celgene Corp (CELG):製薬・医療:M&Aディール及び事業提携情報
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Jeronimo Martins SGPS SA:企業の戦略・SWOT・財務情報
    Jeronimo Martins SGPS SA - Strategy, SWOT and Corporate Finance Report Summary Jeronimo Martins SGPS SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CITIC Ltd (267):電力:M&Aディール及び事業提携情報
    Summary CITIC Limited (CITIC) is a conglomerate company, operating in financial services, resources and energy, manufacturing, engineering contracting, real estate, and other businesses. Financial services include insurance, trust, security, and banking. Resources and energy comprises electricity ge …
  • Northern Power Systems Corp (NPS):企業の財務・戦略的SWOT分析
    Summary Northern Power Systems Corp (NPS), formerly Mira III Acquisition Corp is a renewable energy company that offers engineering solutions to energy sector. The company's products comprise wind turbines, power converters, microgrids, power technology products and others. It offers services such a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆